Incruse Ellipta Dosage
Generic name: UMECLIDINIUM BROMIDE 62.5ug
Dosage form: aerosol, powder
Drug class: Anticholinergic bronchodilators
Medically reviewed by Drugs.com. Last updated on Dec 13, 2023.
The recommended dosage of INCRUSE ELLIPTA for maintenance treatment of COPD is 1 actuation (umeclidinium 62.5 mcg) once daily by oral inhalation.
- •
- INCRUSE ELLIPTA should be used at the same time every day. Do not use INCRUSE ELLIPTA more than 1 time every 24 hours.
- •
- No dosage adjustment is required for geriatric patients, patients with renal impairment, or patients with moderate hepatic impairment [see Clinical Pharmacology (12.3)].
More about Incruse Ellipta (umeclidinium)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (33)
- Side effects
- During pregnancy
- FDA approval history
- Drug class: anticholinergic bronchodilators
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
